| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |